Browse > Article

Induction of Phase I, II and III Drug Metabolism/Transport by Xenobiotics  

Xu Chang Jiang (Department of Pharmaceutics, Ernest Mario School of Pharmacy)
Li Christina YongTao (Department of Pharmaceutics, Ernest Mario School of Pharmacy)
Kong AhNg Tony (Department of Pharmaceutics, Ernest Mario School of Pharmacy)
Publication Information
Archives of Pharmacal Research / v.28, no.3, 2005 , pp. 249-268 More about this Journal
Drug metabolizing enzymes (DMEs) play central roles in the metabolism, elimination and detoxification of xenobiotics and drugs introduced into the human body. Most of the tissues and organs in our body are well equipped with diverse and various DMEs including phase I, phase II metabolizing enzymes and phase III transporters, which are present in abundance either at the basal unstimulated level, and/or are inducible at elevated level after exposure to xenobiotics. Recently, many important advances have been made in the mechanisms that regulate the expression of these drug metabolism genes. Various nuclear receptors including the aryl hydrocarbon receptor (AhR), orphan nuclear receptors, and nuclear factor-erythoroid 2 p45-related factor 2 (Nrf2) have been shown to be the key mediators of drug-induced changes in phase I, phase II metabolizing enzymes as well as phase III transporters involved in efflux mechanisms. For instance, the expression of CYP1 genes can be induced by AhR, which dimerizes with the AhR nuclear translocator (Arnt) , in response to many polycyclic aromatic hydrocarbon (PAHs). Similarly, the steroid family of orphan nuclear receptors, the constitutive androstane receptor (CAR) and pregnane X receptor (PXR), both heterodimerize with the ret-inoid X receptor (RXR), are shown to transcriptionally activate the promoters of CYP2B and CYP3A gene expression by xenobiotics such as phenobarbital-like compounds (CAR) and dexamethasone and rifampin-type of agents (PXR). The peroxisome proliferator activated receptor (PPAR), which is one of the first characterized members of the nuclear hormone receptor, also dimerizes with RXR and has been shown to be activated by lipid lowering agent fib rate-type of compounds leading to transcriptional activation of the promoters on CYP4A gene. CYP7A was recognized as the first target gene of the liver X receptor (LXR), in which the elimination of cholesterol depends on CYP7A. Farnesoid X receptor (FXR) was identified as a bile acid receptor, and its activation results in the inhibition of hepatic acid biosynthesis and increased transport of bile acids from intestinal lumen to the liver, and CYP7A is one of its target genes. The transcriptional activation by these receptors upon binding to the promoters located at the 5-flanking region of these GYP genes generally leads to the induction of their mRNA gene expression. The physiological and the pharmacological implications of common partner of RXR for CAR, PXR, PPAR, LXR and FXR receptors largely remain unknown and are under intense investigations. For the phase II DMEs, phase II gene inducers such as the phenolic compounds butylated hydroxyanisol (BHA), tert-butylhydroquinone (tBHQ), green tea polyphenol (GTP), (-)-epigallocatechin-3-gallate (EGCG) and the isothiocyanates (PEITC, sul­foraphane) generally appear to be electrophiles. They generally possess electrophilic-medi­ated stress response, resulting in the activation of bZIP transcription factors Nrf2 which dimerizes with Mafs and binds to the antioxidant/electrophile response element (ARE/EpRE) promoter, which is located in many phase II DMEs as well as many cellular defensive enzymes such as heme oxygenase-1 (HO-1), with the subsequent induction of the expression of these genes. Phase III transporters, for example, P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and organic anion transporting polypeptide 2 (OATP2) are expressed in many tissues such as the liver, intestine, kidney, and brain, and play crucial roles in drug absorption, distribution, and excretion. The orphan nuclear receptors PXR and GAR have been shown to be involved in the regulation of these transporters. Along with phase I and phase II enzyme induction, pretreatment with several kinds of inducers has been shown to alter the expression of phase III transporters, and alter the excretion of xenobiotics, which implies that phase III transporters may also be similarly regulated in a coordinated fashion, and provides an important mean to protect the body from xenobiotics insults. It appears that in general, exposure to phase I, phase II and phase III gene inducers may trigger cellular 'stress' response leading to the increase in their gene expression, which ultimately enhance the elimination and clearance of these xenobiotics and/or other 'cellular stresses' including harmful reactive intermediates such as reactive oxygen species (ROS), so that the body will remove the 'stress' expeditiously. Consequently, this homeostatic response of the body plays a central role in the protection of the body against 'environmental' insults such as those elicited by exposure to xenobiotics.
Citations & Related Records

Times Cited By Web Of Science : 333  (Related Records In Web of Science)
Times Cited By SCOPUS : 294
연도 인용수 순위
1 Alam, J., Killeen, E., Gong, P., Naquin, R., Hu, B., Stewart, D., Ingelfinger, J. R., and Nath, K. A., Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am. J. Physiol. Renal. Physiol., 284, F743-752 (2003)   DOI
2 Brinkmann, U. and Eichelbaum, M., Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenomics J., 1, 59-64 (2001)   DOI   ScienceOn
3 Chan, L. M., Lowes, S., and Hirst, B. H., The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci., 21, 25-51 (2004)   DOI   ScienceOn
4 Coumoul, X., Diry, M., and Barouki, R., PXR-dependent induc- tion of human CYP3A4 gene expression by organochlorine pesticides. Biochem. Pharmacol., 64, 1513-1519 (2002)   DOI   ScienceOn
5 Dean, M., Hamon, Y., and Chimini, G., The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res., 42, 1007-1017 (2001)
6 del Castillo-Olivares, A. and Gil, G., Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. Nucleic Acids Res., 28, 3587-3593 (2000)   DOI   PUBMED   ScienceOn
7 Dussault, I. and Forman, B. M., The nuclear receptor PXR: a master regulator of 'homeland' defense. Crit. Rev. Eukaryot. Gene Expr., 12, 53-64 (2002)   DOI   ScienceOn
8 Fraser, D. J., Zumsteg, A., and Meyer, U. A., Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. J. Biol. Chem., 278, 39392-39401 (2003)   DOI   ScienceOn
9 Gao, B., Wenzel, A., Grimm, C., Vavricka, S. R., Benke, D., Meier, P. J., and Reme, C. E., Localization of organic anion transport protein 2 in the apical region of rat retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci., 43, 510-514 (2002)
10 Geick, A., Eichelbaum, M., and Burk, O., Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem., 276, 14581-14587 (2001)   DOI   ScienceOn
11 Guenthner, T. M., Qato, M., Whalen, R., and Glomb, S., Similarities between catalase and cytosolic epoxide hydrolase. Drug Metab. Rev., 20, 733-748 (1989)   DOI   ScienceOn
12 Guo, G. L., Choudhuri, S., and Klaassen, C. D., Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. J. Pharmacol. Exp. Ther., 300, 206-212 (2002a)   DOI   ScienceOn
13 Hahn, M. E., Aryl hydrocarbon receptors: diversity and evolution. Chem. Biol. Interact., 141, 131-160 (2002)   DOI   ScienceOn
14 Honkakoski, P. and Negishi, M., Characterization of a pheno- barbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J. Biol. Chem., 272, 14943-14949 (1997)   DOI   ScienceOn
15 Huang, H. C., Nguyen, T., and Pickett, C. B., Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem., 277, 42769-42774 (2002)   DOI   ScienceOn
16 Huang, X., Powell-Coffman, J. A., and Jin, Y., The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydro- carbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans. Development, 131, 819-828 (2004)   DOI   ScienceOn
17 Innocenti, F., Grimsley, C., Das, S., Ramirez, J., Cheng, C., Kuttab-Boulos, H., Ratain, M. J., and Di Rienzo, A., Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Pharmacogenetics, 12, 725-733 (2002)   DOI   ScienceOn
18 Inokuchi, A., Hinoshita, E., Iwamoto, Y., Kohno, K., Kuwano, M., and Uchiumi, T., Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J. Biol. Chem., 276, 46822-46829 (2001)   DOI   ScienceOn
19 Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C., LeCluyse, E. L., Lambert, M.H ., Willson, T. M., Kliewer, S. A., and Moore, J. T., The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol., 14, 27-39 (2000)   DOI   ScienceOn
20 Kikuchi, Y., Ohsawa, S., Mimura, J., Ema, M., Takasaki, C., Sogawa, K., and Fujii-Kuriyama, Y., Heterodimers of bHLH-PAS protein fragments derived from AhR, AhRR, and Arnt prepared by co-expression in Escherichia coli: character- ization of their DNA binding activity and preparation of a DNA complex. J. Biochem. (Tokyo), 134, 83-90 (2003)   DOI   ScienceOn
21 Kim, R. B., Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur. J. Clin. Invest., 33 Suppl 2, 1-5 (2003)   DOI   ScienceOn
22 Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterstrom, R. H., Perlmann, T., and Lehmann, J. M., An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell, 92, 73-82 (1998)   DOI   ScienceOn
23 Konig, J., Rost, D., Cui, Y., and Keppler, D., Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology., 29, 1156-1163 (1999b)   DOI   ScienceOn
24 Kullak-Ublick, G. A., Stieger, B., and Meier, P. J., Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology, 126, 322-342 (2004)   DOI   ScienceOn
25 Kwak, M. K., Itoh, K., Yamamoto, M., and Kensler, T. W., Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol. Cell Biol., 22, 2883-2892 (2002)   DOI   ScienceOn
26 Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., and Kliewer, S. A., The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest., 102, 1016-1023 (1998)   DOI   ScienceOn
27 Levine, S. L. and Perdew, G. H., Aryl hydrocarbon receptor (AhR)/AhR nuclear translocator (ARNT) activity is unaltered by phosphorylation of a periodicity/ARNT/single-minded (PAS)-region serine residue. Mol. Pharmacol., 59, 557-566 (2001)   DOI
28 Li, W., Harper, P. A., Tang, B. K., and Okey, A. B., Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carci- noma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochem. Pharmacol., 56, 599-612 (1998)   DOI   PUBMED   ScienceOn
29 Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., and Kliewer, S. A., Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol., 62, 638-646 (2002)   DOI   ScienceOn
30 Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., and Evans, R. M., Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev., 6, 329-344 (1992)   DOI   ScienceOn
31 Mizuno, N., Niwa, T., Yotsumoto, Y., and Sugiyama, Y., Impact of drug transporter studies on drug discovery and develop- ment. Pharmacol. Rev., 55, 425-461 (2003)   DOI   ScienceOn
32 Nguyen, T., Sherratt, P. J., Huang, H. C., Yang, C. S., and Pickett, C. B., Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem., 278, 4536-4541 (2003)   DOI   ScienceOn
33 Owuor, E. D. and Kong, A. N., Antioxidants and oxidants regulated signal transduction pathways. Biochem. Pharmacol., 64, 765-770 (2002)   DOI   ScienceOn
34 Rushmore, T. H., King, R. G., Paulson, K. E., and Pickett, C. B., Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. U.S.A., 87, 3826-3830 (1990)   DOI
35 Rushmore, T. H. and Kong, A. N., Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab., 3, 481-490 (2002)   DOI   ScienceOn
36 Staudinger, J. L., Madan, A., Carol, K. M., and Parkinson, A., Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos., 31, 523-527 (2003)   DOI   ScienceOn
37 Stewart, D., Killeen, E., Naquin, R., Alam, S., and Alam, J., Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J. Biol. Chem., 278, 2396-2402 (2003)   DOI   ScienceOn
38 Sueyoshi, T. and Negishi, M., Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu. Rev. Pharmacol. Toxicol., 41, 123-143 (2001)   DOI   PUBMED   ScienceOn
39 Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., and Green, S., The mouse peroxisome pro- liferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO. J., 11, 433-439 (1992)
40 Wang, H., Chen, J., Hollister, K., Sowers, L. C., and Forman, B. M., Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell, 3, 543-553 (1999)
41 Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., and Evans, R. M., Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev., 14, 3014-3023 (2000b)   DOI   ScienceOn
42 Zetterstrom, R. H., Solomin, L., Mitsiadis, T., Olson, L., and Perlmann, T., Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol. Endocrinol., 10, 1656-1666 (1996)   DOI   ScienceOn
43 Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., and Moore, D. D., A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell Biol., 14, 1544-1552 (1994)   DOI
44 Johnson, B. M., Charman, W. N., and Porter, C. J., Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A. Drug Metab. Dispos., 31, 1151-1160 (2003)   DOI   ScienceOn
45 Lee, J. M., Hanson, J. M., Chu, W. A., and Johnson, J. A., Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J. Biol. Chem., 276, 20011-20016 (2001)   DOI   ScienceOn
46 Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., and Negishi, M., The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem., 274, 6043-6046 (1999)   DOI   ScienceOn
47 Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., and Evans, R. M., Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature, 406, 435-439 (2000a)   DOI   ScienceOn
48 Elferink, C. J., Aryl hydrocarbon receptor-mediated cell cycle control. Prog. Cell Cycle Res., 5, 261-267 (2003)
49 Ferguson, S. S., LeCluyse, E. L., Negishi, M., and Goldstein, J. A., Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol. Pharmacol., 62, 737-746 (2002)   DOI   ScienceOn
50 Chandra, P. and Brouwer, K. L., The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm. Res., 21, 719-735 (2004)   DOI   ScienceOn
51 Maheo, K., Antras-Ferry, J., Morel, F., Langouet, S., and Guillouzo, A., Modulation of glutathione S-transferase subunits A2, M1, and P1 expression by interleukin-1beta in rat hepatocytes in primary culture. J. Biol. Chem., 272, 16125-16132 (1997)   DOI   ScienceOn
52 Kerb, R., Hoffmeyer, S., and Brinkmann, U., ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics, 2, 51-64 (2001)   DOI   ScienceOn
53 Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., Willson, T. M., Koller, B.H., and Kliewer, S. A., The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U.S.A., 98, 3369-3374 (2001b)   DOI   PUBMED   ScienceOn
54 Bolton, J. L. and Chang, M., Quinoids as reactive intermediates in estrogen carcinogenesis. Adv. Exp. Med. Biol., 500, 497-507 (2001)
55 Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., and Negishi, M., Phenobarbital-responsive nuclear translo- cation of the receptor CAR in induction of the CYP2B gene. Mol. Cell Biol., 19, 6318-6322 (1999)   DOI
56 Menke, J. G., Macnaul, K. L., Hayes, N. S., Baffic, J., Chao, Y. S., Elbrecht, A., Kelly, L. J., Lam, M. H., Schmidt, A., Sahoo, S., Wang, J., Wright, S. D., Xin, P., Zhou, G., Moller, D. E., and Sparrow, C. P., A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a). Endocrinology, 143, 2548-2558 (2002)   DOI   PUBMED   ScienceOn
57 Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., Gonzalez, F. J., Guengerich, F. P., Gunsalus, I. C., Johnson, E. F., et al., The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol., 10, 1-14 (1991)   DOI   ScienceOn
58 Perloff, M. D., von Moltke, L. L., and Greenblatt, D. J., Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats. Xenobiotica, 34, 133-150 (2004)   DOI   ScienceOn
59 Wang, H., Faucette, S., Sueyoshi, T., Moore, R., Ferguson, S., Negishi, M., and LeCluyse, E. L., A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J. Biol. Chem., 278, 14146-14152 (2003)   DOI   ScienceOn
60 Jelinek, D. F., Andersson, S., Slaughter, C. A., and Russell, D. W., Cloning and regulation of cholesterol 7 alpha-hydroxylase,the rate-limiting enzyme in bile acid biosynthesis. J. Biol. Chem., 265, 8190-8197 (1990)
61 Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., and Feingold, K. R., Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun., 293, 145-149 (2002)   DOI   ScienceOn
62 Huang, H. C., Nguyen, T., and Pickett, C. B., Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc. Natl. Acad. Sci. U.S.A., 97, 12475-12480 (2000)   DOI   PUBMED   ScienceOn
63 Konig, J., Nies, A.T., Cui, Y., Leier, I., and Keppler, D., Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta, 1461, 377-394 (1999a)   DOI   ScienceOn
64 Kullak-Ublick, G. A. and Becker, M. B., Regulation of drug and bile salt transporters in liver and intestine. Drug Metab. Rev., 35, 305-317 (2003)   DOI   ScienceOn
65 Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J. M., Hammer, R. E., and Mangelsdorf, D. J., Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell, 93, 693-704 (1998)   DOI   PUBMED   ScienceOn
66 Simpson, A. E., The cytochrome P450 4 (CYP4) family. Gen. Pharmacol., 28, 351-359 (1997)   DOI   ScienceOn
67 Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M. I., Kobayashi, A., Yamamoto, M., Kensler, T. W., and Talalay, P., Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A., 101, 2040-2045 (2004)   DOI   PUBMED   ScienceOn
68 Wolters, H., Elzinga, B. M., Baller, J. F., Boverhof, R., Schwarz, M., Stieger, B., Verkade, H. J., and Kuipers, F., Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice. J. Hepatol., 37, 556-563 (2002)   DOI   ScienceOn
69 Kong, A. N. T., Yu, R., Hebbar, V., Chen, C., Owuor, E., Hu, R., Ee, R., and Mandlekar, S., Signal transduction events elicited by cancer prevention compounds. Mutat. Res., 480-481, 231-241 (2001b)   DOI   ScienceOn
70 Yu, R., Chen, C., Mo, Y. Y., Hebbar, V., Owuor, E. D., Tan, T. H., and Kong, A. N. T., Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J. Biol. Chem., 275, 39907-39913 (2000a)   DOI   ScienceOn
71 Yu, S., Rao, S., and Reddy, J. K., Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr. Mol. Med., 3, 561-572 (2003)   DOI   ScienceOn
72 Coles, B. F., Chen, G., Kadlubar, F. F., and Radominska-Pandya, A., Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. Arch. Biochem. Biophys., 403, 270-276 (2002)   DOI   ScienceOn
73 Fardel, O., Lecureur, V., Corlu, A., and Guillouzo, A., P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem. Pharmacol., 51, 1427-1436 (1996)   DOI   ScienceOn
74 Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D. W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Chowdhury, J. R., Ritter, J. K., Schachter, H., Tephly, T. R., Tipton, K. F., and Nebert, D. W., The UDP glycosyltransferasegene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics, 7, 255-269 (1997)   DOI   ScienceOn
75 Rowlands, J. C. and Gustafsson, J. A., Aryl hydrocarbon receptor-mediated signal transduction. Crit. Rev. Toxicol., 27, 109-134 (1997)   DOI   ScienceOn
76 Shen, G., Hebbar, V., Nair, S. S., Xu, C., Li, W., Lin, W., Keum, Y. S., Han, J., Gallo, M. A., and Kong, A. N., Regulation of Nrf2 transactivation domain activity: The differential effects of mitogen-activated protein kinase cascades and synergistic stimulation effect of Raf and CREB binding protein. J. Biol. Chem., 279, 23052-23060 (2004)   DOI   ScienceOn
77 Meyer, U. A., Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharm., 24, 449-459 (1996)   DOI   PUBMED   ScienceOn
78 Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J., Role of quinones in toxicology. Chem. Res. Toxicol., 13, 135-160 (2000)   DOI   ScienceOn
79 Ramsden, R., Beck, N. B., Sommer, K. M., and Omiecinski, C. J., Phenobarbital responsiveness conferred by the 5'-flanking region of the rat CYP2B2 gene in transgenic mice. Gene, 228, 169-179 (1999)   DOI   PUBMED   ScienceOn
80 Ritter, J. K., Kessler, F. K., Thompson, M. T., Grove, A. D., Auyeung, D. J., and Fisher, R. A., Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology, 30, 476-484 (1999)   DOI   PUBMED
81 Banoglu, E., Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr. Drug Metab., 1, 1-30 (2000)   DOI
82 Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R., and Klaassen, C. D., Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther., 300, 97-104 (2002)   DOI   ScienceOn
83 Dinkova-Kostova, A. T., Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcinogenic enzymes. Mini Rev. Med. Chem., 2, 595-610 (2002a)   DOI   PUBMED   ScienceOn
84 Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J., and Talalay, P., Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl. Acad. Sci. U.S.A., 98, 3404-3409 (2001)   DOI   PUBMED   ScienceOn
85 Hu, R., Hebbar, V., Kim, B. R., Chen, C., Winnik, B., Buckley, B., Soteropoulos, P., Tolias, P., Hart, R. P., and Kong, A. N., In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J. Pharmacol. Exp. Ther. ,(2004)
86 Kong, A. N. T., Yu, R., Chen, C., Mandlekar, S., and Primiano, T., Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch. Pharm. Res., 23, 1-16 (2000)   DOI   ScienceOn
87 Pascussi, J. M., Gerbal-Chaloin, S., Drocourt, L., Maurel, P., and Vilarem, M. J., The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta, 1619, 243-253 (2003b)   DOI   ScienceOn
88 Zhou, Y. C., Davey, H. W., McLachlan, M. J., Xie, T., and Waxman, D. J., Elevated basal expression of liver peroxisomalbeta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways. Toxicol. Appl. Pharmacol., 182, 1-10 (2002)   DOI   PUBMED   ScienceOn
89 Hinson, J. A. and Forkert, P. G., Phase II enzymes and bioactivation. Can. J. Physiol. Pharmacol., 73, 1407-1413 (1995)   DOI   ScienceOn
90 Jelinek, D. F. and Russell, D. W., Structure of the rat gene encoding cholesterol 7 alpha-hydroxylase. Biochemistry, 29, 7781-7785 (1990)   DOI   ScienceOn
91 Kong, A. N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., and Mandlekar, S., Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab. Rev., 33, 255-271 (2001a)   DOI   ScienceOn
92 Staudinger, J., Liu, Y., Madan, A., Habeebu, S., and Klaassen, C. D., Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab. Dispos., 29, 1467-1472 (2001a)
93 Yu, R., Mandlekar, S., Lei, W., Fahl, W. E., Tan, T. H., and Kong, A. N. T., p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J. Biol. Chem., 275, 2322-2327 (2000b)   DOI   ScienceOn
94 Gervois, P., Torra, I. P., Fruchart, J. C., and Staels, B., Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med., 38, 3-11 (2000)   DOI   ScienceOn
95 Gilde, A. J., van der Lee, K. A., Willemsen, P. H., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B., and van Bilsen, M., Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res., 92, 518-524 (2003)   DOI   ScienceOn
96 Guo, G. L., Staudinger, J., Ogura, K., and Klaassen, C. D., Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. Mol. Pharmacol., 61, 832-839 (2002b)   DOI   ScienceOn
97 Jaiswal, A. K., Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression. Pharmacogenetics, 4, 1-10 (1994)   DOI   PUBMED   ScienceOn
98 Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q. H., Owens, I. S., Negishi, M., and Sueyoshi, T., The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology, 33, 1232-1238 (2001)   DOI   ScienceOn
99 Tukey, R. H. and Strassburg, C. P., Human UDP-glucuronosyl- transferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol., 40, 581-616 (2000)   DOI   ScienceOn
100 Gonzalez, F. J. and Nebert, D. W., Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. Trends Genet., 6, 182-186 (1990)   DOI   ScienceOn
101 Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., and Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 236, 313-322 (1997)   DOI   ScienceOn
102 Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., and Sugiyama, Y., Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol. Pharmacol., 53, 1068-1075 (1998)
103 Schilter, B., Turesky, R. J., Juillerat, M., Honegger, P., and Guigoz, Y., Phase I and phase II xenobiotic reactions and metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in aggregating liver cell cultures. Biochem. Pharmacol., 45, 1087-1096 (1993)   DOI   ScienceOn
104 Teng, S., Jekerle, V., and Piquette-Miller, M., Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab. Dispos., 31, 1296-1299 (2003)   DOI   ScienceOn
105 Tugwood, J. D., Aldridge, T. C., Lambe, K. G., Macdonald, N., and Woodyatt, N. J., Peroxisome proliferator-activated receptors: structures and function. Ann. N. Y. Acad. Sci., 804, 252-265 (1996)   DOI   PUBMED
106 Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., and Diehl, J. A., Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell Biol., 23, 7198-7209 (2003)   DOI   ScienceOn
107 Bock, K. W., Gschaidmeier, H., Heel, H., Lehmkoster, T., Munzel, P. A., Raschko, F., and Bock-Hennig, B., AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms. Adv. Enzyme Regul., 38, 207-222 (1998)   DOI   ScienceOn
108 Anakk, S., Kalsotra, A., Kikuta, Y., Huang, W., Zhang, J., Staudinger, J. L., Moore, D. D., and Strobel, H. W., CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J., 4, 91-101 (2004)   DOI   ScienceOn
109 Chan, K. and Kan, Y. W., Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. U.S.A., 96, 12731-12736 (1999)   DOI
110 Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., and Karpen, S. J., The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroen- terology., 121, 140-147 (2001)   DOI   ScienceOn
111 Issemann, I. and Green, S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650 (1990)   DOI   ScienceOn
112 Keum, Y. S., Owuor, E. D., Kim, B. R., Hu, R., and Kong, A. N., Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm. Res., 20, 1351-1356 (2003)   DOI   ScienceOn
113 Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., and Tontonoz, P., Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. U.S.A., 97, 12097-12102 (2000)   DOI   PUBMED   ScienceOn
114 Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., and Kong, A. N. T., Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem., 274, 27545-27552 (1999)   DOI
115 Kumar, R. and Thompson, E. B., The structure of the nuclear hormone receptors. Steroids, 64, 310-319 (1999)   DOI   ScienceOn
116 Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T., Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A., 97, 779-782 (2000)   DOI
117 Turgeon, D., Carrier, J. S., Levesque, E., Hum, D. W., and Belanger, A., Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology., 142, 778-787 (2001)   DOI   ScienceOn
118 Wang, H. and LeCluyse, E. L., Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin. Pharmacokinet., 42, 1331-1357 (2003)   DOI   ScienceOn
119 Bae, Y., Kemper, J. K., and Kemper, B., Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP). DNA Cell Biol., 23, 81-91 (2004)   DOI   ScienceOn
120 Chen, C., Yu, R., Owuor, E. D., and Kong, A. N., Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res., 23, 605-612 (2000)   DOI   ScienceOn
121 Cullinan, S. B. and Diehl, J. A., PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem., 279, 20108-20117 (2004)   DOI   ScienceOn
122 Honkakoski, P., Sueyoshi, T., and Negishi, M., Drug-activated nuclear receptors CAR and PXR. Ann. Med., 35, 172-182 (2003)   DOI   ScienceOn
123 Mangelsdorf, D. J. and Evans, R. M., The RXR heterodimers and orphan receptors. Cell, 83, 841-850 (1995)   DOI   ScienceOn
124 Reichel, C., Gao, B., Van Montfoort, J., Cattori, V., Rahner, C., Hagenbuch, B., Stieger, B., Kamisako, T., and Meier, P. J., Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology, 117, 688-695 (1999)   DOI   ScienceOn
125 Song, X., Xie, M., Zhang, H., Li, Y., Sachdeva, K., and Yan, B., The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes. Drug Metab. Dispos., 32, 35-42 (2004)   DOI   ScienceOn
126 Gonzalez, F. J. and Fernandez-Salguero, P., The aryl hydro- carbon receptor: studies using the AHR-null mice. Drug Metab. Dispos., 26, 1194-1198 (1998)
127 Honkakoski, P., Zelko, I., Sueyoshi, T., and Negishi, M., The nuclear orphan receptor CAR-retinoid X receptor heterodimeractivates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell Biol., 18, 5652-5658 (1998b)   DOI
128 Khan, S. A. and Vanden Heuvel, J. P., Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J. Nutr. Biochem., 14, 554-567 (2003)   DOI   ScienceOn
129 Kwak, M. K., Itoh, K., Yamamoto, M., Sutter, T. R., and Kensler, T. W., Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol. Med., 7, 135-145 (2001)
130 Moscow, J. A. and Dixon, K. H., Glutathione-related enzymes, glutathione and multidrug resistance. Cytotechnology, 12, 155-170 (1993)   DOI   PUBMED
131 Nakajima, M., Iwanari, M., and Yokoi, T., Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. Toxicol. Lett., 144, 247-256 (2003)   DOI   ScienceOn
132 Pascussi, J. M., Dvorak, Z., Gerbal-Chaloin, S., Assenat, E., Maurel, P., and Vilarem, M. J., Pathophysiological factors affecting CAR gene expression. Drug Metab. Rev., 35, 255-268 (2003a)   DOI   ScienceOn
133 Shitara, Y., Sugiyama, D., Kusuhara, H., Kato, Y., Abe, T., Meier, P. J., Itoh, T., and Sugiyama, Y., Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm. Res., 19, 147-153 (2002)   DOI   ScienceOn
134 Tirona, R. G. and Kim, R. B., Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv. Drug Deliv. Rev., 54, 1343-1352 (2002)   DOI   ScienceOn
135 Kang, K. W., Lee, S. J., Park, J. W., and Kim, S. G., Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol., 62, 1001-1010 (2002)   DOI   ScienceOn
136 Schoonjans, K., Staels, B., and Auwerx, J., Role of the peroxi- some proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res., 37, 907-925 (1996)
137 Tzeng, S. J. and Huang, J. D., Transcriptional regulation of the rat Mrp3 promoter in intestine cells. Biochem. Biophys. Res. Commun., 291, 270-277 (2002)   DOI   ScienceOn
138 Guengerich, F. P., Cytochromes p450, drugs, and diseases. Mol. Intervent., 3, 194-204 (2003)   DOI   PUBMED   ScienceOn
139 King, C. D., Rios, G. R., Green, M. D., and Tephly, T. R., UDP-glucuronosyltransferases. Curr. Drug Metab., 1, 143-161 (2000)   DOI   ScienceOn
140 Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., and Shan, B., Identification of a nuclear receptor for bile acids. Science, 284, 1362-1365 (1999)   DOI   PUBMED   ScienceOn
141 Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., Collins, J. L., and Kliewer, S. A., Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem., 275, 15122-15127 (2000)   DOI   ScienceOn
142 Paquet, Y., Trottier, E., Beaudet, M. J., and Anderson, A., Mutational analysis of the CYP2B2 phenobarbital response unit and inhibitory effect of the constitutive androstane receptor on phenobarbital responsiveness. J. Biol. Chem., 275, 38427-38436 (2000)   DOI   ScienceOn
143 Tew, K. D. and Ronai, Z., GST function in drug and stress response. Drug Resist. Updat., 2, 143-147 (1999)   DOI   ScienceOn
144 Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J. M., Evans, D. A., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V. et al., Nomenclature for N-acetyltransferases. Pharmacogenetics., 5, 1-17 (1995)   DOI   ScienceOn
145 Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., and Talalay, P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A., 99, 11908-11913 (2002b)   DOI   PUBMED   ScienceOn
146 Goodwin, B., Hodgson, E., D'Costa, D. J., Robertson, G. R., and Liddle, C., Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol., 62, 359-365 (2002)   DOI   ScienceOn
147 Lehmann, J. M., Kliewer, S. A, Moore, L. B., Smith-Oliver, T. A, Oliver, B. B., Su, J. L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T A., and Willson, T M., Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. BioI. Chem., 272, 3137-3140 (1997)   DOI   ScienceOn
148 Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W., P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42 (1996)   DOI   ScienceOn
149 Willson, T. M. and Kliewer, S. A., PXR, CAR and drug metabolism. Nat. Rev. Drug Discov., 1, 259-266 (2002)   DOI   ScienceOn
150 Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., and Evans, R. M., An essential role for nuclear receptors SXR/PXR in detoxificationof cholestatic bile acids. Proc. Natl. Acad. Sci. U.S.A., 98, 3375-3380 (2001)   DOI   PUBMED   ScienceOn
151 Xiong, H., Yoshinari, K., Brouwer, K. L., and Negishi, M., Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab. Dispos., 30, 918-923 (2002)   DOI   ScienceOn
152 Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., and Edwards, P. A., Regulation of multidrug resistance-associatedprotein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem., 277, 2908-2915 (2002)   DOI   ScienceOn
153 Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C.,Her, C., and Raftogianis, R. B., Sulfation and sulfotransferases1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J., 11, 3-14 (1997)   DOI
154 Heid, S. E., Pollenz, R. S., and Swanson, H. I., Role of heat shock protein 90 dissociation in mediating agonist-induced activation of the aryl hydrocarbon receptor. Mol. Pharmacol., 57, 82-92 (2000)
155 Honkakoski, P., Moore, R., Washburn, K. A., and Negishi, M., Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol. Pharmacol., 53, 597-601 (1998a)   DOI
156 Lambe, K. G. and Tugwood, J. D., A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur. J. Biochem., 239, 1-7 (1996)   DOI   ScienceOn
157 Lewis, D. F., P450 structures and oxidative metabolism of xenobiotics. Pharmacogenomics, 4, 387-395 (2003)   DOI   PUBMED   ScienceOn
158 Waxman, D. J., P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys., 369, 11-23 (1999)   DOI   PUBMED   ScienceOn
159 Wei, P., Zhang, J., Dowhan, D. H., Han, Y., and Moore, D. D., Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J., 2, 117-126 (2002)   DOI   ScienceOn